<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Opinion
          Home / Opinion / Global Lens

          AI sparking a global health revolution

          By Roland Eils and Gu Lei | China Daily | Updated: 2025-05-28 06:52
          Share
          Share - WeChat
          MA XUEJING/CHINA DAILY

          Imagine a world where diseases are spotted before they strike, health is monitored by a digital guardian and treatments are perfectly tailored. This is no longer a distant dream but an emerging reality supercharged by artificial intelligence, big data and digital health. These technologies are rewriting global public health, offering a more reliable way to better predict illnesses, closely monitor people's well-being, treat them with pinpoint accuracy, and make healthcare fairer and faster. To achieve this, we need a strong, equitable worldwide healthcare system.

          Think of AI and big data as health super-sleuths. They sift through mountains of health data, spotting patterns humans might miss, making disease prediction sharper. The large language model of DeepSeek shows promise in understanding medical conversations and helping doctors read scans for early signs of trouble, which means quicker help and access to fairer medical knowhow.

          AI analysis of electronic health records can flag risks which can lead to hundreds of diseases later in life and years before the onset of the disease. This is vital for spotting individuals vulnerable to diseases during health scares. A simple, cheap AI-read eye scan could soon predict the risks for many conditions including type 2 diabetes, making large-scale, cost-effective early disease detection feasible.

          AI-powered wearables and health apps are becoming personal health coaches, tracking body signals, lifestyle and the environment to warn of risks and offer tailored advice. AI analysis of our unique chemical signature readily obtained from a single blood draw can predict multi-disease risk and track health in detail. This proactive approach is key to chronic disease control and boosting health literacy.

          AI also personalizes treatment. By crunching patient data and medical studies, AI can help understand diseases, find new drug targets and predict treatment responses. It can spot patient subgroups who will respond best to specific therapies and help expedite the discovery of new medicines and testing methods, making access to life-saving drugs faster.

          AI, big data and digital health technologies are transforming healthcare, making it more efficient, accessible and equitable. By automating administrative tasks, optimizing hospital work-flows, and supporting faster, more accurate diagnoses, AI reduces the burden on medical workers and shortens patients' wait time. Advanced large language models such as DeepSeek can provide expert-level medical support for remote and underserved regions, helping bridge the gap in access to quality medical care.

          These innovations play a vital role in addressing global healthcare disparities. Low-cost AI-powered health apps and virtual consultations extend high-quality medical services to communities with limited resources. When trained on diverse medical data, AI systems offer accurate predictions for a wide range of population groups, including those historically underrepresented. Affordable diagnostic tools, such as AI-analyzed retinal scans and chemical signature tests, further democratize access to vital health information, paving the way for more inclusive and proactive healthcare worldwide.

          While the promise of AI in healthcare is immense, ensuring its safe, ethical and equitable use requires thoughtful regulation. Regulations for AI in healthcare markedly differs across the European Union, the United States and China. The EU leads with its comprehensive AI Act, classifying health-related AI as high-risk, and requiring strict oversight and compliance. Its General Data Protection Regulation enforces rigorous data privacy, emphasizing individual rights and explicit consent.

          The US lacks a unified AI law, relying on the FDA for case-by-case regulation for AI in healthcare, and the Health Insurance Portability and Accountability Act for data privacy, which is less stringent than the EU's GDPR.

          China, on the other hand, has adopted a strategic, State-guided approach, embedding AI governance within broader national frameworks. While it has no standalone AI law, it issues detailed ethical guidelines and uses the Personal Information Protection Law to regulate health data, emphasizing consent and data localization.

          These different models — the EU's rights-based, the US' innovation-driven, and China's State-coordinated — reflect distinct policy priorities and cultural values shaping the global landscape of AI in healthcare. Given China's rapid pace of AI innovation and strong State coordination, the country is well positioned to accelerate the use of AI-driven healthcare solutions from urban centers to remote rural areas.

          In doing so, China can serve as a global role model by demonstrating how digital health technologies can promote equity and transform public health at scale. We are entering a new era of data-driven, AI-enabled public health. To seize the opportunities offered by this advancement, we need global cooperation, interdisciplinary research and shared ethical principles. By embracing these technologies responsibly and inclusively, we can build a smarter, fairer and healthier world for all.

          Roland Eils is a member of Leopoldina National Academy of Sciences, Germany and is promoting AI healthcare applications in Berlin and Shanghai.
          Gu Lei is a principal investigator, exploring environmental-genetic interactions with the integration of AI at the Max Planck Institute for Heart and Lung Research.

          The views don't necessarily reflect those of China Daily.

          If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn, and comment@chinadaily.com.cn.

          Most Viewed in 24 Hours
          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          主站蜘蛛池模板: 公交车最后一排| 中文字幕无码精品亚洲35| 欧美日韩视频综合一区无弹窗| 日本午夜精品一区二区三区电影| 日韩精品中文字幕有码| 欧美大片va欧美在线播放| 痉挛高潮喷水av无码免费| blued视频免费观看片| 精品日韩精品国产另类专区| 90后极品粉嫩小泬20p| 人妻无码中文专区久久app| 青青青国产在线观看免费| 日本在线视频www色影响网站 | 国产成人高清精品免费软件| 久9视频这里只有精品| 中文亚洲爆乳av无码专区| 欧美人成精品网站播放| 国产精品一区二区婷婷| 国产精品视频第一第二区| 亚洲国产精品丝袜在线观看| 欧美成人在线免费| 卡一卡2卡3卡精品网站| 日韩精品少妇无码受不了| 久久国产精品亚洲精品99| 在线国产综合一区二区三区| 国产精品一区二区不卡91| 亚洲日韩国产精品第一页一区| 中文字幕无码免费不卡视频| 久久精品国产热久久精品国产亚洲| 亚洲少妇人妻无码视频| 伊人久久大香线蕉成人| 18黑白丝水手服自慰喷水| 亚洲人成电影网站 久久影视| 欧美日韩综合在线精品| 福利视频一区二区在线| 天堂网亚洲综合在线| 国产成人无码免费视频在线| 99国产欧美另类久久片| 91高清免费国产自产拍| 国产精品综合色区在线观看| 国产激情一区二区三区不卡|